Vascular Pathways

Parents

*Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
*Industry: Northern California & Silicon Valley
C. R. Bard, Inc. (NYSE: BCR), Inc: #27. Medical Devices, (2013)-CCF/CeMBR
Companies: Acquired_(M&A)

Also participating were St. Louis-based Ascension Health Ventures, London-based MVM Life Science Partners and New York-based Arc
Despite this decades-old problem, there has been little innovation aimed towards addressing this substantial unmet medical need.
Lead investor in the round was Stamford, Conn.-based CHL Medical Partners.
Los Altos, California
Medical device company with a breakthrough product for peripheral intravenous access
More than 300 million peripheral intravenous catheters are placed in patients in the United States alone each year, and current
Nelson K. Stacks, interim chief executive officer (2010)
Proceeds of the Series B round will be used to commercialize the company’s U.S. FDA cleared Rapid Intravascular Start (RIVS) IV
The novel but simple design of the RIVS catheter enables reproducibly rapid, easy and safe insertion of the device by all traine
Vascular Pathways raises $14 million Series B (2010)
Vascular Pathways, founded by Amir Belson, M.D.